BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 16080648)

  • 21. Clinical strategy in hereditary hemorrhagic telangiectasia.
    Kühnel TS; Wagner BH; Schurr CP; Strutz J
    Am J Rhinol; 2005; 19(5):508-13. PubMed ID: 16270607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of haemorrhagic telangiectasia with the flashlamp-pulsed dye laser.
    Ducic Y; Brownrigg P; Laughlin S
    J Otolaryngol; 1995 Oct; 24(5):299-302. PubMed ID: 8537990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Injections of fibrin glue in severe epistaxis and Rendu-Osler disease].
    Martin H; Martin C
    Ann Otolaryngol Chir Cervicofac; 1984; 101(7):561-3. PubMed ID: 6334470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rendu-Osler-Weber's disease and the rhinologist].
    Wentges RT; Brinkman WF
    Ned Tijdschr Geneeskd; 1972 Oct; 116(42):1880-4. PubMed ID: 4641013
    [No Abstract]   [Full Text] [Related]  

  • 25. Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization.
    Trojanowski P; Jargiello T; Trojanowska A; Klatka J
    Acta Radiol; 2011 Oct; 52(8):846-9. PubMed ID: 21816895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epistaxis in Rendu-Weber-Osler disease. The role of brachytherapy].
    Turcato G; Pizzi GB; Polico R; Antonello M; Busetto M
    Acta Otorhinolaryngol Ital; 1996 Dec; 16(6):513-6. PubMed ID: 9381921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary hemorrhagic telangiectasia: a review of 76 cases.
    Shah RK; Dhingra JK; Shapshay SM
    Laryngoscope; 2002 May; 112(5):767-73. PubMed ID: 12150604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous embolization to control epistaxis in Rendu-Osler-Weber disease.
    Strother CM; Newton TH
    Arch Otolaryngol; 1976 Jan; 102(1):58-60. PubMed ID: 1244834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis.
    Folz BJ; Wollstein AC; Lippert BM; Werner JA
    Am J Rhinol; 2005; 19(1):65-70. PubMed ID: 15794077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rendu-Osler-Weber disease].
    Sys L; van den Hoogen FJ
    Ned Tijdschr Tandheelkd; 2005 Sep; 112(9):336-9. PubMed ID: 16184912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bilateral closure of the nasal cavity. An original surgical technique of treatment of severe recurrent epistaxis in Rendu-Osler disease].
    Serrano E; Percodani J; Pessey JJ
    Ann Otolaryngol Chir Cervicofac; 1998 Jun; 115(3):169-73. PubMed ID: 9765720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local sclerotherapy with polydocanol (Aethoxysklerol®) for the treatment of Epistaxis in Rendu-Osler-Weber or Hereditary Hemorrhagic Telangiectasia (HHT): 15 years of experience.
    Morais D; Millás T; Zarrabeitia R; Botella LM; Almaraz A
    Rhinology; 2012 Mar; 50(1):80-6. PubMed ID: 22469609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Maxillary artery embolisation as a method of treatment of hemorrhages in Rendu-Osler-Weber Syndrome--our experience].
    Barnaś S; Wilczyński K; Kiszka M; Gerber-Sekula A; Nowicki J
    Otolaryngol Pol; 2007; 61(5):884-6. PubMed ID: 18552041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relapsing epistaxis: embolization as treatment of choice].
    Moz U; Grandini M; Rosa G; Valvassori L
    Acta Otorhinolaryngol Ital; 1995 Aug; 15(4):312-6. PubMed ID: 8928664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of superselective embolization of the maxillary artery in treatment of bleedings in the Rendu-Osler-Weber syndrome].
    Kantor I; Winiarski M; Jurkiewicz D; Osiecki M; Brzozowski K
    Otolaryngol Pol; 2005; 59(2):215-7. PubMed ID: 16095090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
    Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Office-based sclerotherapy for recurrent epistaxis due to hereditary hemorrhagic telangiectasia: a pilot study.
    Boyer H; Fernandes P; Duran O; Hunter D; Goding G
    Int Forum Allergy Rhinol; 2011; 1(4):319-23. PubMed ID: 22287439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nd:YAG laser treatment of recurrent epistaxis in heredity hemorrhagic telangiectasia.
    Velegrakis GA; Prokopakis EP; Papadakis CE; Helidonis ES
    J Otolaryngol; 1997 Dec; 26(6):384-6. PubMed ID: 9438937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Embolization of branches of the external carotid artery in nosebleeds complicating Rendu-Osler-Weber disease].
    Nekipelov EF; Serbinenko FA
    Zh Vopr Neirokhir Im N N Burdenko; 1983; (4):23-33. PubMed ID: 6624354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Fiorella ML; Ross D; Henderson KJ; White RI
    Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.